Although evidence from non-small-cell lung cancer (NSCLC) patients indicates that high FADD mRNA expression correlates with a poor survival prognosis (Chen et al., 2005), mechanistic insight into this correlation is lacking. This evidence concerns the gene FADD and non-small cell lung carcinoma.